Hamps Bio Limited IPO
Open Demat Account
Hamps Bio Limited IPO Details
Details
Total Shares Offered | Offer to Public | Retail Max (Shares) | Pre Issue Promoters Holding | Exchange | Issue size |
---|---|---|---|---|---|
₹ 12.2 L | TBA | ₹ 5.8 L | ₹ 31.36 L | BSE | TBA |
IPO Open Date | Close Date | Lot Size | Min Investment | Issue Type | Listing Date |
13 Dec, 24 | 17 Dec, 24 | 2000 | TBA | Fixed Price - SME | 20 Dec, 24 |
Hamps Bio Limited IPO Dates
Details
Sector | Type |
---|---|
Sector | Trading |
Sub Sector | NA |
Issue Type | Fixed Price - SME |
Subscription Status
*Values are in Lakhs
Investor Type | Subscription Times | Shares Offered* | Shares Bid* |
---|---|---|---|
QIB | 0x | 0 | 0 |
NII | 0x | 578000 | 0 |
Retail | 0x | 580000 | 0 |
Employee | 0x | 0 | 0 |
Total | 0x | 1220000 | 0 |
Subscription Status
Investor Type
QIB
NII
Retail
Employee
Total
*Values are in Lakhs
Hamps Bio Limited Financial Status
Income Statement
Balance Sheet
Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
---|---|---|---|
Revenue from operations | 1.05 | 0.70 | 0.43 |
EBITDA | 1.45 | 1.04 | 0.76 |
PAT | 0.50 | 0.36 | 0.12 |
Total Assets | 2.49 | 1.27 | 1.37 |
Share Capital | 1.96 | 1.50 | 1.50 |
Total Borrowings | 1.10 | 1.39 | 1.71 |
Operating Activities (Net Cash) | 0.90 | 0.70 | 0.45 |
Investing Activities (Net Cash) | 0.00 | 0.00 | 0.04 |
Financing Activities (Net Cash) | 1.10 | 1.39 | 1.71 |
Net Cashflow | 0.06 | 0.05 | 0.05 |
Particulars (in Rs. Crores)
Revenue from operations
EBITDA
PAT
Total Assets
Share Capital
Total Borrowings
Operating Activities (Net Cash)
Investing Activities (Net Cash)
Financing Activities (Net Cash)
Net Cashflow
About Hamps Bio Limited
Our Company was originally incorporated under the name Hamps Bio Private Limited under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli on January 02, 2007. Subsequently, the status of the Company was changed to public limited and the name of our Company was changed to Hamps Bio Limited vide Special Resolution passed by the Shareholders at the Extra Ordinary General Meeting of our Company held on June 08, 2023. The fresh certificate of incorporation consequent to conversion was issued on July 12, 2023 by the Registrar of Companies, Ahmedabad, Gujarat. The Corporate Identification Number of our Company is U24233GJ2007PLC049692.
India plays an important role in the global pharmaceuticals and vaccine industry. It is the largest provider of generic medicines globally. The country has a share of 20% in the global supply volume and contributes to around 60% of the global vaccines. India ranks third in the world in terms of volume and is the fourteenth largest in terms of value. Key segments of the Indian pharmaceutical industry are OTC medicines, Generics, APIs, Vaccines, Biosimilars, and Custom Research Manufacturing (CRM). The FMCG sector in India expanded due to consumer-driven growth and higher product prices, especially for essential goods. FMCG sector provides employment to around 3 million people accounting for approximately 5% of the total factory employment in India. FMCG sales in the country was expected to grow 7-9% by revenues in 2022-23. The key growth drivers for the sector include favourable Government initiatives & policies, a growing rural market and youth population, new branded products, and growth of e-commerce platforms. Resilience needs to be the key factor in the manufacturing process, daily operations, retail and logistic channels, consumer insights and communication that will help FMCG companies to withstand the test of time and create more value for consumers in the long run.
We are engaged in the ethical marketing and distribution of pharmaceutical formulation products (Pharma) across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products (FDFP) such as fruits, vegetables, herbs and flowers. We are recognized in the pharmaceutical industry under our own brand name Hamps and in freeze-dried and frozen food segment through our own brand FzyEzy. We sell our products through more than 50 distributor's network as on October 31, 2024 and E-commerce platform, including Amazon.com, Amazon.ca, Amazon.eu, Flipkart, Jio Mart, Etc. We sell our pharma products primarily in 8 States and Union territories and our FDFP products primarily in 6 countries and 22 States and Union territories. As on the date of this Prospectus, we had a range of more than 180 different products sold across both the segments.
Peer Comparison:
- No Listed Industry Peers
Hamps Bio Limited IPO Key Points
Strengths
- Expert Leadership and Industry Experience driving Strategic Business Growth.
- Distribution Network with Expansive E-Retailing Presence.
- Wide and diversified range of products.
- Diversified, global customer base with long standing relationships.
- Wide Geographical Presence.
Risk
- The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.
- The company does not have its own manufacturing facility for pharmaceutical products and the company has to relies on third parties for procuring pharmaceutical products sold by the Company.
- Its existing manufacturing facility for freeze dried and frozen products is concentrated in a single region i.e., Ankelshwar, Gujarat and the inability to operate and grow its business in this particular region may have an adverse effect on its business, financial condition, results of operations, cash flows and future business prospects.
Strategy
- Capital Expenditure to meet the growing demand of FDFP products.
- Increasing our Domestic and Global presence.
- Enhancing our Branding.
- Reduction of operational costs and achieving efficiency.
- Strengthen Marketing Network.
- Expert Leadership and Industry Experience driving Strategic Business Growth.
- Distribution Network with Expansive E-Retailing Presence.
- Wide and diversified range of products.
- Diversified, global customer base with long standing relationships.
- Wide Geographical Presence.
How To Apply for Hamps Bio Limited IPO Online?
Step 1:
Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.
Step 2:
From the list of open IPOs, select the IPO you want to invest.
Step 3:
Go through the IPO details like lot size, price band, about the company, etc.
Step 4:
Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.
Step 5:
Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.